Literature DB >> 21148536

First case of New Delhi metallo-beta-lactamase 1-producing Escherichia coli infection in Japan.

Shingo Chihara, Katsuko Okuzumi, Yoshitaka Yamamoto, Shinji Oikawa, Akira Hishinuma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21148536     DOI： 10.1093/cid/ciq054

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  17 in total

1.  Sensitive and rapid detection of the new Delhi metallo-beta-lactamase gene by loop-mediated isothermal amplification.

Authors:  Wei Liu; Dayang Zou; Yan Li; Xuesong Wang; Xiang He; Xiao Wei; Changlin Shao; Xuelian Li; Wei Shang; Kaitao Yu; Dawei Liu; Yunmei Li; Jing Guo; Zhitao Yin; Jing Yuan
Journal:  J Clin Microbiol       Date:  2012-02-22       Impact factor: 5.948

2.  NDM-1 and the Role of Travel in Its Dissemination.

Authors:  Mary Elizabeth Wilson; Lin H Chen
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

3.  A structural view of the antibiotic degradation enzyme NDM-1 from a superbug.

Authors:  Yu Guo; Jing Wang; Guojun Niu; Wenqing Shui; Yuna Sun; Honggang Zhou; Yaozhou Zhang; Cheng Yang; Zhiyong Lou; Zihe Rao
Journal:  Protein Cell       Date:  2011-06-02       Impact factor: 14.870

4.  When carbapenem-hydrolyzing beta-lactamase Kpc meets Escherichia coli ST131 in France.

Authors:  Thierry Naas; Gaelle Cuzon; Olivier Gaillot; René Courcol; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

5.  SMB-1, a novel subclass B3 metallo-beta-lactamase, associated with ISCR1 and a class 1 integron, from a carbapenem-resistant Serratia marcescens clinical isolate.

Authors:  Jun-ichi Wachino; Hiroyuki Yoshida; Kunikazu Yamane; Satowa Suzuki; Mari Matsui; Takuya Yamagishi; Atsuko Tsutsui; Toshifumi Konda; Keigo Shibayama; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

6.  In vivo efficacy of human simulated regimens of carbapenems and comparator agents against NDM-1-producing Enterobacteriaceae.

Authors:  Dora E Wiskirchen; Patrice Nordmann; Jared L Crandon; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2013-12-30       Impact factor: 5.191

Review 7.  Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy.

Authors:  Constance Schultsz; Suzanne Geerlings
Journal:  Drugs       Date:  2012-01-01       Impact factor: 11.431

8.  Complete sequencing of the bla(NDM-1)-positive IncA/C plasmid from Escherichia coli ST38 isolate suggests a possible origin from plant pathogens.

Authors:  Tsuyoshi Sekizuka; Mari Matsui; Kunikazu Yamane; Fumihiko Takeuchi; Makoto Ohnishi; Akira Hishinuma; Yoshichika Arakawa; Makoto Kuroda
Journal:  PLoS One       Date:  2011-09-23       Impact factor: 3.240

9.  Successful treatment of septic shock due to New Delhi metallo-β-lactamase-1-producing Klebsiella pneumoniae in a patient transferred from India to Japan.

Authors:  Hideki Kano; Akihiko Hirakawa; Hiromiti Miyabe; Tomonori Hattori; Hiroshige Mikamo; Shunji Yoshida; Naoshi Takeyama
Journal:  Acute Med Surg       Date:  2014-04-23

10.  Search of potential inhibitor against New Delhi metallo-beta-lactamase 1 from a series of antibacterial natural compounds.

Authors:  Prasoon Kumar Thakur; Jitender Kumar; Divya Ray; Farah Anjum; Md Imtaiyaz Hassan
Journal:  J Nat Sci Biol Med       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.